Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16 studies found for:    fluorocholine
Show Display Options
Rank Status Study
1 Recruiting Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Other: F-18-FCH & Ga-68-NODAGA-MJ9
2 Completed
Has Results
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: IV administration of fluorine-18 fluorocholine followed by PET/CT imaging
3 Unknown  [18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases
Condition: Prostate Cancer
Intervention: Procedure: [18F] Fluorocholine PET/CT
4 Completed Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography
Condition: Prostate Cancer
Intervention: Device: Fluourine-18 Fluoromethylcholine PET/CT Imaging
5 Recruiting 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases
Condition: Brain Metastases
Intervention: Procedure: 18F-FCH PET Scan
6 Unknown  The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer
Condition: Prostate Cancer
7 Unknown  Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
Condition: Prostate Cancer
8 Recruiting 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Fluorocholine (18F-FCH) Injection;   Radiation: PET scan;   Radiation: Whole body MRI
9 Recruiting Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
Conditions: Breast Cancer Diagnosis;   Positron Emission Tomography;   Magnetic Resonance Imaging
Interventions: Drug: 18F-FCH;   Drug: Magnevist
10 Not yet recruiting To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Disease
Interventions: Drug: 18F- fluorocholine;   Drug: 18F- fluorodeoxyglucose
11 Recruiting 18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: [F-18]-FCH;   Radiation: PET scan;   Radiation: MRI scan
12 Unknown  Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy
Condition: Glioma
13 Recruiting Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Fluoromethylcholine (FCH) PET/CT Imaging
14 Not yet recruiting PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy
Condition: Prostate Cancer
Intervention: Device: 18F-FCH PET/MRI Scan
15 Recruiting Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: 18F-FCH PET/MRI imaging
16 Unknown  Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer
Condition: Prostate Cancer
Intervention: Device: performance of PET/CT and  whole-body MRI

Indicates status has not been verified in more than two years